Skip to main content
Enveric Biosciences, Inc. logo

Enveric Biosciences, Inc. — Investor Relations & Filings

Ticker · ENVB ISIN · US02362F3029 US Professional, scientific and technical activities
Open in API
Filings indexed 1,029 across all filing types
Latest filing 2022-07-05 Director's Dealing
Country US United States of America
Listing US ENVB

About Enveric Biosciences, Inc.

https://www.enveric.com/

Enveric Biosciences is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of neuropsychiatric disorders. The company focuses on conditions such as anxiety, depression, and addiction. Leveraging its proprietary discovery and development platform, The Psybrary™, Enveric has created a robust intellectual property portfolio of novel molecules for specific mental health indications. Its development pipeline includes candidates such as EB-003 for difficult-to-treat mental health disorders and the EVM301 series.

Recent filings

Filing Released Lang Actions
Director's Dealing 2022
Director's Dealing
2022-07-05 English
Director's Dealing 2022
Director's Dealing
2022-06-22 English
Board/Management Information 2022
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated June 13, 2022, by Enveric Biosciences, Inc. The key content is the announcement of the appointment of two new directors to the board and their committee assignments. There is no financial data or report attached, nor is this a full annual or quarterly report. The document specifically relates to changes in the company's board of directors. According to the filing definitions, announcements of changes in the company's board or senior management fall under Board/Management Information (MANG). The document length is under 5,000 characters and is a direct announcement, not a report publication or certification. Therefore, the correct classification is MANG with high confidence.
2022-06-15 English
Proxy Solicitation & Information Statement 2022
Proxy Solicitation & Information Statement
2022-05-31 English
Investor Presentation 2022
Investor Presentation Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 20, 2022, by Enveric Biosciences, Inc. It specifically mentions in Item 7.01 Regulation FD Disclosure that an investor presentation is attached as Exhibit 99.1. The text clarifies that the presentation is for investor communication and may be used at conferences. There is no detailed financial data or comprehensive report content within the text itself, only a reference to the attached investor presentation. The document is about disclosing an investor presentation rather than the presentation itself or a full financial report. Therefore, the filing type corresponds to an Investor Presentation (IP). The document length is 4863 characters, which is sufficient to contain substantive content, but the content is clearly an 8-K filing referencing an investor presentation, not the presentation itself. Hence, the classification is IP with high confidence.
2022-05-24 English
Proxy Solicitation & Information Statement 2022
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14A Proxy Statement filed with the SEC, as indicated by the header and form type 'PRE 14A'. It is a solicitation of proxies for a Special Meeting of Stockholders of Enveric Biosciences, Inc. The text includes detailed information about the meeting date, voting procedures, proposals to be voted on (such as a reverse stock split and amendments to the incentive plan), and instructions for stockholders. It does not contain financial statements or earnings data, nor is it an announcement of results or a report. The document is clearly a proxy solicitation material, which corresponds to the Proxy Solicitation & Information Statement category (PSI). The document length (15,000 characters) and content confirm it is the full proxy statement, not just an announcement or notice. Therefore, the correct classification is PSI with high confidence.
2022-05-20 English

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.